SG3 Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-10,000
Closed -$394K 346
2022
Q2
$394K Sell
10,000
-41,300
-81% -$2.21M 0.05% 226
2022
Q1
$3.59M Buy
+51,300
New +$3.75M 0.1% 188
2020
Q1
Sell
-18,500
Closed -$1.71M 390
2019
Q4
$1.71M Buy
+18,500
New +$1.63M 0.11% 73

Other funds holding EXAS

SG3 Management's EXAS Position: Q1 2023 in Review

SG3 Management sold out of Exact Sciences (EXAS) in Q1 2023, closing a stake of 12,000 shares — an estimated $594K sold.

SG3 Management first reported a position in EXAS in Q1 2022 and held it in 2 quarters. The position peaked at $594K in Q4 2022. 583 funds tracked by Wall St. Rank hold EXAS as of Q1 2023.

  • SG3 Management reported no remaining Exact Sciences position as of Q1 2023 after selling out during the quarter.
  • SG3 Management sold 12,000 Exact Sciences shares in Q1 2023, an estimated $594K.
  • SG3 Management first reported a position in Exact Sciences in Q1 2022 and held it in 2 quarters.
  • SG3 Management's Exact Sciences position peaked at $594K in Q4 2022.
  • 583 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2023.

Based on SG3 Management's 13F filing for Q1 2023, filed 15 May 2023.